drugset / Trial / NCT05393050

Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis

NCT05393050 ↗

Phase 4 Unknown 120 enrolled Quan Jiang
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a multi-center, randomized, double-blinded, controlled trial with two parallel arms. The aim of the study is to evaluate whether Colquhounia Root Tablet combined with methotrexate (MTX) might be better than MTX alone for patients with active rheumatoid arthritis (RA).

Timeline

Start
2022-07
Primary completion
2023-12
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colquhounia Root Tablet Unknown 0.54 g —
Comparator Methotrexate Small molecule 10 mg —

Indications